To evaluate the relevance of ER in HER2 transcription, we evaluated HER2 mRNA levels in ER-positive BC cell lines (BT474, MDAMB361 and ZR75.30) treated or not treated with fulvestrant, a selective ER degrader. Here, ERBB2 is linked to breast cancer.